Literature DB >> 7947533

Semi-quantitative human papillomavirus DNA detection in the management of women with minor cytological abnormality.

M E Mansell1, L Ho, G Terry, A Singer, J Cuzick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7947533     DOI: 10.1111/j.1471-0528.1994.tb11952.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


× No keyword cloud information.
  6 in total

1.  Withdrawing low risk women from cervical screening programmes: mathematical modelling study.

Authors:  C Sherlaw-Johnson; S Gallivan; D Jenkins
Journal:  BMJ       Date:  1999-02-06

2.  A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA.

Authors:  D C Swan; R A Tucker; B P Holloway; J P Icenogle
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

3.  Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type.

Authors:  D C Swan; R A Tucker; G Tortolero-Luna; M F Mitchell; L Wideroff; E R Unger; R A Nisenbaum; W C Reeves; J P Icenogle
Journal:  J Clin Microbiol       Date:  1999-04       Impact factor: 5.948

4.  Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer.

Authors:  Jo L K Cheung; Tak-Hong Cheung; Candy W Y Ng; Mei Y Yu; Martin C S Wong; Shing-Shun N Siu; So-Fan Yim; Paul K S Chan
Journal:  J Clin Microbiol       Date:  2008-11-26       Impact factor: 5.948

5.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Authors:  C L Peyton; M Schiffman; A T Lörincz; W C Hunt; I Mielzynska; C Bratti; S Eaton; A Hildesheim; L A Morera; A C Rodriguez; R Herrero; M E Sherman; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

6.  Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions.

Authors:  G Terry; L Ho; P Londesborough; J Cuzick
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.